CN Patent

CN118477074A — 一种奥美沙坦酯氨氯地平药物组合物及其制备方法

Assigned to Jiangsu Hechen Pharmaceutical Co ltd · Expires 2024-08-13 · 2y expired

What this patent protects

本发明涉及医药技术领域，具体公开了一种奥美沙坦酯氨氯地平药物组合物及其制备方法，以奥美沙坦酯和苯磺酸氨氯地平为原料，包括一种或多种可药用的赋形剂，其制备方法是将奥美沙坦酯和苯磺酸氨氯地平和可选择的填充剂、崩解剂混合均匀后，采用干法制粒工艺进行制粒，然后再与润滑剂混合后压片、包衣，从而解决了压片过程中下料不畅的问题。

USPTO Abstract

本发明涉及医药技术领域，具体公开了一种奥美沙坦酯氨氯地平药物组合物及其制备方法，以奥美沙坦酯和苯磺酸氨氯地平为原料，包括一种或多种可药用的赋形剂，其制备方法是将奥美沙坦酯和苯磺酸氨氯地平和可选择的填充剂、崩解剂混合均匀后，采用干法制粒工艺进行制粒，然后再与润滑剂混合后压片、包衣，从而解决了压片过程中下料不畅的问题。

Drugs covered by this patent

Patent Metadata

Patent number
CN118477074A
Jurisdiction
CN
Classification
—
Expires
2024-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hechen Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.